Maravai LifeSciences Holdings Inc’s filing revealed that its General Counsel ORESHACK KURT unloaded Company’s shares for reported $0.13 million on Jan 31 ’25. In the deal valued at $5.03 per share,25,000 shares were sold. As a result of this transaction, ORESHACK KURT now holds 167,618 shares worth roughly $0.33 million.
Then, ORESHACK KURT bought 25,000 shares, generating $125,750 in total proceeds.
Before that, DeFord John A bought 17,500 shares. Maravai LifeSciences Holdings Inc shares valued at $100,625 were divested by the Director at a price of $5.75 per share. As a result of the transaction, DeFord John A now holds 70,046 shares, worth roughly $0.14 million.
Robert W. Baird downgraded its Maravai LifeSciences Holdings Inc [MRVI] rating to a Neutral from a an Outperform in a research note published on February 26, 2025; the price target was decreased to $3 from $9. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in mid December with a ‘”a Neutral”‘ rating. Goldman also remained covering MRVI and has decreased its forecast on December 05, 2024 with a “Sell” recommendation from previously “Neutral” rating. Wolfe Research started covering the stock on November 14, 2024. It rated MRVI as “a Peer perform”.
Price Performance Review of MRVI
On Friday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock fall -7.62% to $1.94. Over the last five days, the stock has lost -17.80%. Maravai LifeSciences Holdings Inc shares have fallen nearly -64.40% since the year began. Nevertheless, the stocks have fallen -77.47% over the past one year. While a 52-week high of $11.56 was reached on 01/08/25, a 52-week low of $2.07 was recorded on 04/04/25. SMA at 50 days reached $3.4357, while 200 days put it at $6.3337.
Levels Of Support And Resistance For MRVI Stock
The 24-hour chart illustrates a support level at 1.8483, which if violated will result in even more drops to 1.7567. On the upside, there is a resistance level at 2.0583. A further resistance level may holdings at 2.1767. The Relative Strength Index (RSI) on the 14-day chart is 25.29, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1963, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.22%. Stochastics %K at 11.45% indicates the stock is a buying.
How much short interest is there in Maravai LifeSciences Holdings Inc?
A steep rise in short interest was recorded in Maravai LifeSciences Holdings Inc stocks on 2025-03-14, growing by 1.3 million shares to a total of 11.6 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 10.3 million shares. There was a rise of 11.24%, which implies that there is a positive sentiment for the stock.